Clinical Considerations - Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults

Published: 06/01/2021

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

According to the U.S. Centers for Disease Control and Prevention (CDC), since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna), particularly in adolescents and young adults. There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson).

In most cases, patients who presented for medical care have responded well to medicatio

Sign Up for Free Trial